New Biomarker Test Allows Early Detection of Adverse Prognosis after Acute ... - PR Newswire (press release) Print
PR Newswire (press release)
"This study describes a new biomarker (NGAL) that completely outperforms the current serum creatinine-based criteria for the early detection of AKI and its devastating clinical outcomes," said Prasad Devarajan, MD, director of Nephrology and

...